Blood Glucose Test Strips Market to Reach US$ 21.67 Billion by 2033 at 6.0% CAGR; North America Leads with 40% Share - Key Players: Roche, LifeScan, Ascensia

Blood Glucose Test Strips Market reached US$ 12.84 billion in 2024 and is expected to reach US$ 21.67 billion by 2033, growing at a CAGR of 6.0% during the forecast period 2025-2033. The market is experiencing steady growth due to the rising global prevalence of diabetes, increasing adoption of self-monitoring of blood glucose (SMBG), and growing awareness regarding early disease management. The expanding elderly population, sedentary lifestyles, and rising obesity rates are further contributing to the increasing demand for blood glucose test strips worldwide.
The blood glucose test strips market includes electrochemical and photometric strips, which are widely used with glucometers for routine glucose monitoring. Electrochemical test strips dominate the market due to their higher accuracy, faster response time, and lower blood sample requirements. Market growth is further supported by technological advancements such as improved enzyme formulations, enhanced strip sensitivity, and integration with digital health platforms and mobile apps. Additionally, favorable reimbursement policies in developed regions, expanding healthcare access in emerging economies, and the growing emphasis on home-based diabetes management are strengthening the global blood glucose test strips market outlook.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/blood-glucose-test-strips-market?sai-v

The Blood Glucose Test Strips Market is the sector that manufactures and supplies disposable test strips used with glucose meters to measure blood glucose levels for diabetes management.

Key Developments
✅ October 2025: Healthcare providers and pharmacies in North America supplied blood glucose test strips for use in blood glucose monitoring by patients with diabetes.

✅ September 2025: European clinical laboratories and diabetes care centers processed blood glucose test strips as part of routine glucose monitoring protocols for patients.

✅ August 2025: Asia-Pacific hospitals and outpatient clinics distributed blood glucose test strips to support self-monitoring of blood glucose levels among diabetes patients.

✅ July 2025: Manufacturers produced standardized blood glucose test strips compatible with a range of glucose meters used in home and clinical settings.

✅ May 2025: Retail pharmacies and medical supply distributors expanded availability of blood glucose test strips for insulin-dependent and non-insulin-dependent diabetes management.

✅ March 2025: Regulatory authorities reviewed labeling, quality, and safety standards for approved blood glucose test strips marketed for diabetes care.
Mergers & Acquisitions

✅ November 2025: A global medical devices company acquired a blood glucose monitoring solutions provider, including its test strip product offerings.

✅ August 2025: A European diabetes care technology firm partnered with a healthcare provider network to supply blood glucose test strips integrated with diabetes management programs.

✅ June 2025: An Asia-Pacific healthcare products company acquired a test strip manufacturing business to strengthen its portfolio of diabetes self-monitoring supplies.

Key Players
ARKRAY, Inc. | Ascensia Diabetes Care India | Roche Diabetes Care Limited | LifeScan IP Holdings, LLC. | CLIAwaived, Inc. | AgaMatrix | DarioHealth Corp. | Universal Biosensors | HMD Biomedical Inc. | B. Braun SE | Others

Key Highlights
Roche Diabetes Care Limited holds a share of 24.8 percent, driven by its strong global presence in blood glucose monitoring systems, trusted Accu-Chek product portfolio, and extensive clinical adoption across hospitals and homecare settings.

LifeScan IP Holdings, LLC. accounts for 20.6 percent, supported by the widespread use of OneTouch glucose monitoring devices, strong brand recognition, and continuous innovation in connected diabetes management solutions.

Ascensia Diabetes Care India captures 15.3 percent, benefiting from its Contour series glucose meters, strong penetration in emerging markets, and focus on accuracy-driven diabetes testing solutions.

ARKRAY, Inc. represents 12.9 percent, leveraging its expertise in diagnostic technologies, diversified glucose monitoring products, and solid footprint across Asia-Pacific and European markets.

B. Braun SE holds 8.7 percent, supported by its integrated diabetes care offerings, hospital-focused diagnostics, and strong relationships with healthcare providers.

AgaMatrix accounts for 6.4 percent, driven by its emphasis on high-accuracy glucose meters and partnerships with digital health and insulin delivery platforms.

DarioHealth Corp. captures 4.9 percent, focusing on digital-first glucose monitoring systems that integrate mobile applications, remote monitoring, and personalized diabetes insights.

Universal Biosensors holds 3.2 percent, supported by its proprietary biosensor technology and collaborations with global diagnostic companies.

HMD Biomedical Inc. represents 2.1 percent, driven by cost-effective glucose monitoring solutions and growing adoption in price-sensitive markets.

CLIAwaived, Inc. accounts for 0.7 percent, focusing on point-of-care and waived laboratory glucose testing solutions for clinics and small healthcare facilities.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=blood-glucose-test-strips-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers
- Increasing prevalence of diabetes (both type 1 and type 2) requiring frequent monitoring of blood glucose levels.

- Growing awareness and emphasis on diabetes self-management and early detection of glycemic fluctuations.

- Expansion of diabetes screening and monitoring programs supported by government and healthcare initiatives.

- Advancements in glucose monitoring technologies improving accuracy, ease of use, and affordability.

- Rising adoption of home care diagnostics and connected glucose monitoring devices (e.g., smart meters, mobile app integration).

- Increasing healthcare expenditure and access to diabetes care in emerging markets.

- Supportive reimbursement policies and insurance coverage for diabetes testing supplies.

Industry Developments
- Launch of next-generation blood glucose test strips compatible with advanced glucometers and digital platforms.

- Development of test strips with enhanced sensitivity, smaller sample volume requirements, and faster response times.

- Integration of test strip data with mobile apps and cloud-based health record systems to support remote monitoring.

- Collaborations between diagnostic manufacturers, healthcare providers, and digital health vendors.

- Expansion of distribution networks through pharmacies, retail outlets, and e-commerce channels.

- Increasing mergers, acquisitions, and strategic investments in diabetes care technology portfolios.

- Introduction of value-added services such as subscription delivery models for test strips and consumables.

Regional Insights
North America - 40% share: "Driven by high diabetes prevalence, strong screening programs, widespread self-monitoring adoption, and supportive reimbursement frameworks."

Europe - 30% share: "Supported by established healthcare systems, growing awareness of diabetes management, and increasing use of advanced monitoring solutions."

Asia Pacific - 24% share: "Fueled by large diabetic population, expanding healthcare access, rising income levels, and growing adoption of home glucose monitoring tools."

Latin America - 4% share: "Boosted by improving diabetes care infrastructure, rising awareness, and expanding availability of test strips."

Middle East & Africa - 2% share: "Driven by growing prevalence of diabetes, gradual improvement in healthcare access, and increasing focus on chronic disease monitoring."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/blood-glucose-test-strips-market?sai-v

Key Segments
By Strip Type
Thin film strips dominate the market due to their high accuracy, faster response time, and lower blood sample requirements, making them widely preferred for routine glucose monitoring. Thick film strips continue to hold a significant share as they are cost-effective and commonly used in standard blood glucose meters, particularly in emerging markets. Optical strips represent a niche but growing segment, supported by advancements in non-invasive and minimally invasive glucose monitoring technologies.

By Diabetes Type
Type II diabetes accounts for the largest share of the market, driven by its high global prevalence and the need for regular blood glucose monitoring as part of long-term disease management. Type I diabetes represents a significant segment, as patients require frequent and lifelong glucose testing to manage insulin therapy effectively. Gestational diabetes is witnessing steady growth due to increasing screening rates during pregnancy and rising maternal health awareness. Prediabetes is an emerging segment, supported by growing emphasis on early diagnosis, preventive care, and lifestyle management to delay or prevent disease progression.

By End-User
Homecare dominates the market as self-monitoring of blood glucose becomes increasingly common among diabetic and prediabetic individuals, supported by easy-to-use testing strips and portable glucose meters. Hospitals account for a significant share, particularly for inpatient monitoring and acute diabetes management. Diagnostic centers continue to expand their usage for routine screening and confirmatory testing. Ambulatory surgical centers contribute steadily to market demand through perioperative glucose monitoring and outpatient care services.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.